Pharma Marketing Network

APRIL 2, 2025

Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. Pharmaceutical brands like Dupixent, Keytruda, and Ozempic are leading the way with creative digital campaigns that blend patient education with dynamic storytelling.

Marketing 64

Marketing Pharma Sales pitches Networking 64

Pharma Marketing Network

MARCH 13, 2025

Artificial intelligence is revolutionizing how pharma brands engage with healthcare professionals (HCPs) and patients, optimizing advertising campaigns, and improving customer experiences. Those that embrace AI-driven marketing solutions will see higher engagement, better ROI, and improved patient outcomes.

Marketing 52

Marketing Pharma Medical Ethics 52

Pharma Marketing Network

DECEMBER 4, 2024

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. Patient-Centric Marketing Patients want to feel heard.

Marketing 52

Marketing Pharma Media Education 52

Pharma Marketing Network

MARCH 20, 2025

Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. In pharma marketing, ad retargeting plays a crucial role in educating patients and HCPs about new treatments, clinical trials, and brand offerings.

Pharma 52

Pharma Networking Marketing Media 52

Pharma Marketing Network

DECEMBER 31, 2024

Are you targeting healthcare providers (HCPs), patients, or payers? Craft a Patient-Centric Approach Todays consumers want more than medication; they want solutions. For instance, campaigns for branded drugs like Lipitor and Jardiance have gained traction by focusing on patients real-life experiences.

Marketing 52

Marketing Pharmaceutical Pharma Education 52

Pharma Marketing Network

MARCH 6, 2025

Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. The way HCPs, patients, and caregivers seek information has changed. Animations explaining drug mechanisms attract HCPs and patients alike.

Media 52

Media Pharma Education Networking 52

Pharma Marketing Network

MARCH 5, 2025

Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? Reaching Healthcare Professionals (HCPs) HCPs dont search the way patients do.

Pharma 52

Pharma Networking Medical Healthcare 52

pharmaphorum

SEPTEMBER 28, 2022

The FDA has published draft guidance giving its position on the ethical reasons for including children in clinical trials, and protecting them from harm. ” The post FDA sets out its thinking on protecting children in clinical trials appeared first on.

FDA 59

FDA Ethics Prospecting Safety 59

European Pharmaceutical Review

DECEMBER 13, 2022

The UK’s regulatory pathway and fast-track drug approval process enables companies to fast-track their ethics applications and combine their reviews. The regulators are the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) respectively.

Medicine 105

Medicine Food and Drug Administration Ethics Government 105

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. Marketing to rare disease patient populations is equal parts opportunity and responsibility. audiences (direct-to-patient advertising rules are fundamentally different overseas).

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52

Pharmaceutical Technology

JANUARY 11, 2023

The US Food and Drug Administration (FDA) has granted Fast Track designation for UNION therapeutics’ oral orismilast to treat moderate-to-severe hidradenitis suppurativa (HS). The post US FDA grants Fast Track status for UNION’s oral orismilast to treat HS appeared first on Pharmaceutical Technology.

Food and Drug Administration 52

Food and Drug Administration FDA Ethics Food 52

European Pharmaceutical Review

JUNE 28, 2023

Approval “for a Phase II study should provide us with a strong efficacy signal and expedite our pathway to approval for MSP-1014 as a new effective and more tolerable treatment for patients suffering from MDD,” added Mindset Pharma’s Chief Scientific Officer Araujo. Psychedelic medicines: are they gaining traction in Europe?

Ethics 97

Ethics Medicine Pharma FDA 97

Clarivate

NOVEMBER 13, 2023

Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and payers. A clinical outcome assessment is a measure that describes or reflects how a patient feels, functions or survives.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Pharma Marketing Network

OCTOBER 24, 2024

As more patients turn to digital platforms for information and brands compete in an increasingly crowded market, pharma marketers need to be agile, creative, and tech-savvy to succeed. Websites, mobile apps, and digital ads are more than just tools—they are lifelines connecting pharma companies to healthcare professionals and patients.

Marketing 52

Marketing Healthcare Healthcare Pharma 52

Pharma Marketing Network

DECEMBER 19, 2024

In pharma marketing, targeting the right patients and providers ensures that every dollar spent delivers value, engagement, and, most importantly, trust. Patients: The End Consumers Patients are at the heart of pharma marketing. Patients: Highlight lifestyle benefits, such as convenience or improved quality of life.

Marketing 52

Marketing Pharma Patients Media 52

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

PM360

APRIL 22, 2024

Leveraging the power of social media influencers either through patients, caregivers, or HCPs, pharmaceutical companies are navigating novel ways to communicate with potential consumers and prescribers. Aside from adhering to FTC and FDA regulations, which is an absolute must, there are additional factors that should be considered.

Healthcare 75

Healthcare Healthcare Media Pharmaceutical 75

Pharma Marketing Network

JANUARY 29, 2025

In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. AI-powered chatbots, predictive modeling, and automated sales reps are reshaping HCP engagement and patient support. For patients, omnichannel marketing is about seamless communication.

Marketing 52

Marketing Pharma Pharmaceutical Ethics 52

Pharma Marketing Network

OCTOBER 29, 2024

Connecting with patients, healthcare providers, and caregivers online builds trust, enhances engagement, and strengthens brand loyalty. With more people relying on the internet for health information, a strong online presence is vital for pharma companies to educate audiences, enhance brand loyalty, and improve patient outcomes.

Healthcare 52

Healthcare Healthcare Marketing Pharma 52

Pharma Marketing Network

JANUARY 9, 2025

With rising competition, stricter regulations, and increasingly informed patients, the landscape has transformed dramatically. Patient-Centric Marketing: Putting Patients First Pharma marketing is no longer just about doctors and decision-makers. Patients now play a central role in the conversation.

Marketing 52

Marketing Pharmaceutical Pharma Ethics 52

pharmaphorum

NOVEMBER 16, 2022

Having presented the data from the 24-month phase 3 trial at the American Academy of Ophthalmology (AAO) annual meeting, Dr Wykoff set aside some time to go into further detail with pharmaphorum about how the results were received, and what glimmer of hope this might hold for patients with GA. Working against the odds. “As

Safety 105

Safety Patients Prospecting Consulting 105

Rep-Lite

APRIL 4, 2024

Sales representatives play a crucial role in connecting healthcare facilities with innovative technologies that improve patient care. While the rewards can be significant, carving a successful path in this field requires a unique blend of technical knowledge, interpersonal skills, and a commitment to ethical practices.

Sales 52

Sales Medical Interpersonal Skills Healthcare Provider 52

European Pharmaceutical Review

MARCH 12, 2024

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Ethical leadership is essential in promoting a culture of integrity within an organisation. What is an effective solution?

Government 98

Government Pharma Training Ethics 98

eMediWrite

SEPTEMBER 24, 2024

Recognize the journey of the patient Pharma marketers must thoroughly understand the entire patient journey, from the beginning of symptoms to diagnosis, treatment, and follow-up care. By meeting patients where they are and providing the appropriate message at the right moment, they can increase the possibility of their interaction.

Marketing 52

Marketing Pharma Ethics Healthcare 52

Clarivate

MARCH 17, 2022

Experts at a November 2021 Food and Drug Administration (FDA) meeting also wrestled with this theme of clinical trials and pregnancy. Ahead of the meeting, the FDA highlighted nonclinical findings (i.e., We look at the outcome of a recent Food and Drug Administration meeting and their draft guidance for more information.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

Nixon Gwilt Law

APRIL 22, 2024

Appropriate: Guarantees that DSIs are suitable for the contexts and populations in which they are used, adhering to relevant clinical and ethical standards. Effective: Ensures that DSIs achieve their intended outcomes, improving clinical decision-making and patient care. Pro Tip: We are in a moment of transition.

Healthcare 52

Healthcare Healthcare Training Food and Drug Administration 52

Pharmaceutical Technology

JANUARY 23, 2023

However, this progress is not reflected with respect to approved treatments for paediatric IBD patients. Therefore, with an inadequate or loss of response to these anti-TNFs, clinicians must prescribe adult therapies off-label to treat younger patients.

Medical 59

Medical Ethics Specialization Physicians 59

Pharma Marketing Network

MARCH 3, 2025

Introduction In the fast-changing world of pharmaceutical marketing , programmatic advertising has revolutionized the way brands reach healthcare professionals (HCPs) and patients. How do you maximize your return on investment (ROI) while ensuring your campaigns remain ethically and legally sound ?

Pharma 52

Pharma Networking Marketing FDA 52

European Pharmaceutical Review

JANUARY 9, 2024

Adding these developments with the addition of connected IoT devices, supply chain restructuring and consideration for our code of ethics will give us a glimpse at how pharmaceutical production will look in future. Internet] US Food and Drug Administration (FDA). Tuijin Jishu / Propuls. 2023; 44(3):1384-1392. cited 2023Dec].

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

Nixon Gwilt Law

NOVEMBER 16, 2023

For instance, AI systems can interpret complex medical data, make decisions based on that data, and even interact with patients using natural language processing. As we explore each area, you'll find out how these AI applications can impact the company you’re building and the potential legal and ethical hurdles you might face.

Healthcare 52

Healthcare Healthcare Ethics Training 52

Pharma Marketing Network

MARCH 20, 2025

Patients and healthcare providers alike turn to online platforms for research, engagement, and decision-making. Additionally, evolving patient expectations demand more personalized and seamless experiences. Prioritize Data Privacy : Collecting and using patient data must comply with stringent privacy regulations.

Marketing 52

Marketing Healthcare Healthcare Pharma 52

Nixon Gwilt Law

APRIL 22, 2024

Appropriate: Guarantees that DSIs are suitable for the contexts and populations in which they are used, adhering to relevant clinical and ethical standards. Effective: Ensures that DSIs achieve their intended outcomes, improving clinical decision-making and patient care. Pro Tip: We are in a moment of transition.

Healthcare 52

Healthcare Healthcare Training Food and Drug Administration 52

PM360

SEPTEMBER 30, 2024

for Your Brand, Company, or the Industry as a Whole Building trust equity in the pharmaceutical industry hinges on a commitment to transparency, reliability, and ethical practices. PM360 asked a few specialists to share their intake on building trust equity with patients in the industry. So, how do we fix this?

Ethics 59

Ethics Pharma Side effects Healthcare 59

Rep-Lite

MAY 10, 2024

From groundbreaking advancements in technology to a growing emphasis on patient-centricity, the industry is constantly evolving. In recent years, shifts in healthcare regulations, including updates in FDA guidelines and compliance standards, have significantly impacted sales representatives and healthcare providers alike.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

pharmaphorum

NOVEMBER 3, 2022

Food and Drug Administration’s (FDA) draft guidance, “ Digital Health Technologies for Remote Data Acquisition in Clinical Investigations ”. Other tools enhance patient centricity, inclusivity, generalisability of findings, participant retention, and technical success, while reducing timelines. Moving towards implementation.

Pharma 81

Pharma Medicine Education Recruitment 81

Clarivate

JUNE 28, 2024

The artificial intelligence (AI) revolution has created a remarkable opportunity to transform medical diagnostics by significantly enhancing the accuracy, speed, and efficiency of diagnosing patients. One of the primary barriers is the disagreement in data protection and the lack of compatibility with ethical aspects.

Healthcare 52

Healthcare Healthcare Medical Healthcare Provider 52

Pharma Marketing Network

DECEMBER 4, 2024

Marketing pharma has become a complex and competitive field, with companies vying for the attention of healthcare providers (HCPs), patients, and regulators alike. From strict regulatory environments to growing patient expectations, the industry requires a delicate balance of innovation and compliance. The good news?

Competition 52

Competition Marketing Pharma Media 52